Roche Aktie
| 285,90CHF | 0,20CHF | 0,07% |
WKN: 855167 / ISIN: CH0012032048
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 100,00 |
| Vanguard Total International Stock Index Fund | 1,38 |
| Vanguard Developed Markets Index Fund | 0,85 |
| Vanguard Institutional Total Intl. Stock Market Index Tr. II | 0,70 |
| CSIF (CH) Umbrella - Eq. Switzerland Total Market Index Blue | 0,60 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 101 465 | 100 920 | 103 613 | 103 605 | 103 249 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,57 | 0,62 | 0,61 | 0,57 | 0,59 |
Bilanz (in Mio. CHF) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 32 942 | 35 627 | 33 816 | 33 446 | 40 036 |
| Summe Anlagevermögen | 53 196 | 56 690 | 54 335 | 57 022 | 61 765 |
| Summe Aktiva | 86 138 | 92 317 | 88 151 | 90 468 | 101 801 |
Bilanz (in Mio. CHF) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 46 365 | 63 972 | 56 136 | 57 205 | 65 640 |
| Summe Eigenkapital | 39 773 | 28 345 | 32 015 | 33 263 | 36 161 |
| Summe Passiva | 86 138 | 92 317 | 88 151 | 90 468 | 101 801 |
Adresse
| Grenzacherstrasse 124, 4058 Basel | |
| Telefon | +41 (61) 688-11-11 |
| Internet | http://www.roche.com |
Management
|
Akiko Iwasaki
Director |
|
Alan Hippe
Chief Financial & Information Officer |
|
André S. Hoffmann
Vice Chairman |
|
Anita Hauser
Independent Non-Executive Director |
|
Boris Zaïtra
Head-Corporate Business Development |
|
Bruno Eschli
Head-Investor Relations |
|
Claudia Boeckstiegel
General Counsel |
|
Claudia Süssmuth Dyckerhoff
Independent Non-Executive Director |
|
Cristina A. Wilbur
Chief People Officer |
|
Hans Clevers
Head-Pharma Research & Early Development |
|
Jemilah Mahmood
Director |
|
Joerg Duschmale
Independent Non-Executive Director |
|
Levi A. Garraway
Chief Medical Officer & Head-Product Development |
|
Pascale Schmidt
Chief Compliance Officer |
|
Patrick Frost
Independent Non-Executive Director |
|
Per-Olof Attinger
Secretary |
|
Richard P. Lifton
Independent Non-Executive Director |
|
Severin Schwan
Chairman |
|
Silke Hörnstein
Head-Corporate Strategy & Sustainability |
|
Thomas Schinecker
Chief Executive Officer |
|
Ulf Mark Schneider
Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.